22ND CENTURY GROUP INC (XXII) Forecast, Price Target & Analyst Ratings

NASDAQ:XXII • US90137F6088

3.93 USD
-0.06 (-1.5%)
Last: Mar 5, 2026, 10:50 AM

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for 22ND CENTURY GROUP INC (XXII).

Forecast Snapshot

Consensus Price Target

Price Target
$137.70
+ 3,403.82% Upside

Next Earnings Forecast

Earnings Estimate
Release DateMar 18, 2026
PeriodQ4 / 2025
EPS Estimate-$7.50
Revenue Estimate4.182M

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$137.70
Upside
+ 3,403.82%
From current price of $3.93 to mean target of $137.70, Based on 7 analyst forecasts
Low
$136.35
Median
$137.70
High
$141.75

Price Target Revisions

1 Month
1,400.00%
3 Months
1,828.57%

Price Target Summary

7 analysts have analysed XXII and the average price target is 137.7 USD. This implies a price increase of 3403.82% is expected in the next year compared to the current price of 3.93.
The average price target has been revised upward by 1828.57% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

XXII Current Analyst RatingXXII Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

XXII Historical Analyst RatingsXXII Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
XXII was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about XXII.
In the previous month the buy percentage consensus was at a similar level.
XXII was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-08-23Roth MKMReiterate Buy -> Buy
2023-08-17Alliance Global PartnersDowngrade Buy -> Neutral
2023-08-15TD CowenDowngrade Outperform -> Market Perform
2023-08-15Dawson JamesMaintains Buy -> Buy
2022-11-09Alliance Global PartnersMaintains Buy
2022-07-21Alliance Global PartnersInitiate Buy
2022-06-15Craig-HallumInitiate Buy
2022-03-08Roth CapitalInitiate Buy
2021-07-23Cowen & Co.Initiate Outperform

Next Earnings Forecast Details

Next Earnings Details

Release DateMar 18, 2026
PeriodQ4 / 2025
EPS Estimate-$7.50
Revenue Estimate4.182M
Revenue Q2Q4.00%
EPS Q2Q-53.64%
Number of Analysts3

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-12.77%
EPS (1 Month)
0.00%
EPS (3 Months)
-3,240.91%

Next Earnings Summary

XXII is expected to report earnings on 3/18/2026. The consensus EPS estimate for the next earnings is -7.5 USD and the consensus revenue estimate is 4.18M USD.
The next earnings revenue estimate has been revised downward by 12.77% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026
Revenue
YoY % growth
XXII revenue by date.XXII revenue by date.
40.501M
30.87%
32.204M
-20.49%
24.382M
-24.29%
18.462M
-24.28%
33.15M
79.56%
EBITDA
YoY % growth
XXII ebitda by date.XXII ebitda by date.
-30.058M
-10.97%
-38.323M
-27.50%
-12.817M
66.56%
-11.322M
11.66%
2.856M
125.23%
EBIT
YoY % growth
XXII ebit by date.XXII ebit by date.
-32.916M
-16.17%
-42.274M
-28.43%
-13.82M
67.31%
-12.067M
12.69%
-1.734M
85.63%
Operating Margin
XXII operating margin by date.XXII operating margin by date.
-81.27%-131.27%-56.68%-65.36%-5.23%
EPS
YoY % growth
XXII eps by date.XXII eps by date.
-208,656.00
-33.33%
-369,122.40
-76.90%
N/A
99.99%
-27.85
-37.16%
-2.91
89.56%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-7.50
-53.64%
-4.28
92.55%
-0.06
99.97%
-0.02
99.87%
0.18
102.45%
Revenue
Q2Q % growth
4.182M
4.00%
4.702M
-21.05%
7.63M
86.87%
8.588M
114.11%
12.23M
192.44%
EBITDA
Q2Q % growth
-2.754M
10.84%
-1.326M
43.48%
612K
124.27%
918K
136.46%
2.754M
200.00%
EBIT
Q2Q % growth
-3.131M
23.48%
-2.132M
17.05%
-540.6K
81.87%
-224.4K
93.01%
1.163M
137.14%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

XXII Yearly Revenue VS EstimatesXXII Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
XXII Yearly EPS VS EstimatesXXII Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 -1M -2M -3M -4M -5M

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

22ND CENTURY GROUP INC / XXII Forecast FAQ

What is the price target for XXII stock?

7 analysts have analysed XXII and the average price target is 137.7 USD. This implies a price increase of 3403.82% is expected in the next year compared to the current price of 3.93.


When does 22ND CENTURY GROUP INC (XXII) report earnings?

22ND CENTURY GROUP INC (XXII) will report earnings on 2026-03-18, after the market close.


Can you provide the consensus estimates for 22ND CENTURY GROUP INC next earnings?

The consensus EPS estimate for the next earnings of 22ND CENTURY GROUP INC (XXII) is -7.5 USD and the consensus revenue estimate is 4.18M USD.


How do analysts rate 22ND CENTURY GROUP INC (XXII)?

The consensus rating for 22ND CENTURY GROUP INC (XXII) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.